Symbiotix Biotherapies, Inc. logo

Symbiotix Biotherapies, Inc.

Symbiotix Biotherapies, Inc. is developing a novel class of molecular therapeutics based on molecules derived from the human microbiome. Emerging from over a decade of research at Brigham & Women’s Hospital/Harvard Medical School, California Institute of Technology and Dartmouth College by our company’s scientific founders, distinguished thought leaders in the microbiome field, Symbiotix is rapidly moving forward translational activities to bring to market Reglemers™, first-in-class molecules that modulate the activity of regulatory T cells.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://symbiotix-bio.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
One International Place Suite 1400, MA 02110
Boston
United States
Email
Contact Number
+1 617-535-3196

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/symbiotix-biotherapies” connections=”true” suffix=””]